Abstract:Recent evidence shows that activation of microglia releases various proinflammatory cytokines and neurotoxic mediators, which plays an important role in the pathogenesis of chronic pain. Toll-like receptor 4 (TLR4) on the microglia is the main receptor on the cell membrane for the Gram-negative bacteria cell-wall component. Both nuclear factor kappa B (NF-κB) and mitogen activated protein kinases (MAPkinases) mediate production of proinflammatory cytokines in many types of cells, however, the signal pathways and relationship in details are not very clear in microglia. Here, we investigated the effects of KDO2 (a new TLR4 agonist) on the highly aggressively proliferating immortalized (HAPI) cells that had been enriched for microglia. KDO2 treatment significantly induced the phosphorylation of c-Jun N-terminal kinase (JNK) and NF-κB, but not p38, and released TNFα and IL-1β. The knockdown of TLR4 with TLR4 siRNA significantly reduced the expression of phosphorylation of JNK (pJNK) and phosphorylation of NF-κB (pNF-κB), TNFα, and IL-1β. Inhibition of JNK reduced the release of TNFα, but not phosphorylation of NF-κB. Inhibition of NF-κB reduced the release of IL-1β; unexpectedly, inhibition of NF-κB enhanced pJNK and release of TNFα. These findings showed that TNFα induced by KDO2 was JNK-dependent, and that NF-κB negatively modulated both pJNK and TNFα in the cultured microglial cells. The current study may provide a new insight in the modulation of cytokines in the microglial cells. Recent evidence shows that activation of microglia releases various proinflammatory cytokines and neurotoxic mediators, which plays an important role in the pathogenesis of chronic pain. Toll-like receptor 4 (TLR4) on the microglia is the main receptor on the cell membrane for the Gram-negative bacteria cell-wall component. Both nuclear factor kappa B (NF-κB) and mitogen activated protein kinases (MAPkinases) mediate production of proinflammatory cytokines in many types of cells, however, the signal pathways and relationship in details are not very clear in microglia. Here, we investigated the effects of KDO2 (a new TLR4 agonist) on the highly aggressively proliferating immortalized (HAPI) cells that had been enriched for microglia. KDO2 treatment significantly induced the phosphorylation of c-Jun N-terminal kinase (JNK) and NF-κB, but not p38, and released TNFα and IL-1β. The knockdown of TLR4 with TLR4 siRNA significantly reduced the expression of phosphorylation of JNK (pJNK) and phosphorylation of NF-κB (pNF-κB), TNFα, and IL-1β. Inhibition of JNK reduced the release of TNFα, but not phosphorylation of NF-κB. Inhibition of NF-κB reduced the release of IL-1β; unexpectedly, inhibition of NF-κB enhanced pJNK and release of TNFα. These findings showed that TNFα induced by KDO2 was JNK-dependent, and that NF-κB negatively modulated both pJNK and TNFα in the cultured microglial cells. The current study may provide a new insight in the modulation of cytokines in the microglial cells.

Tnf Alpha And Il-1 Beta Are Mediated By Both Tlr4 And Nod1 Pathways In The Cultured Hapi Cells Stimulated By Lps

TNFα and IL-1β are mediated by both TLR4 and Nod1 pathways in the cultured HAPI cells stimulated by LPS.

Modulations of Proinflammatory Cytokines by NF-kappaB and JNK in HAPI Cells Treated with a New TLR4 Agonist KDO2

Phosphodiesterase 4B is Required for NLRP3 Inflammasome Activation by Positive Feedback with Nrf2 in the Early Phase of LPS- Induced Acute Lung Injury

Crosstalk Between JNK and NF-κB in the KDO2-Mediated Production of TNFα in HAPI Cells

TLR Signaling Adaptor Protein MyD88 in Primary Sensory Neurons Contributes to Persistent Inflammatory and Neuropathic Pain and Neuroinflammation

TLR4 signaling pathway mediates the LPS/ischemia-induced expression of monocytechemotactic protein-induced protein 1 in microglia

IL-1β and TNF-α induce neurotoxicity through glutamate production: a potential role for neuronal glutaminase.

TLR4-TAK1-p38 MAPK pathway and HDAC6 regulate the expression of sigma-1 receptors in rat primary cultured microglia

Enhancement by Interleukin-1β of AMPA and NMDA Receptor-Mediated Currents in Adult Rat Spinal Superficial Dorsal Horn Neurons

The role of TLR4-mediated PTEN/PI3K/AKT/NF-κB signaling pathway in neuroinflammation in hippocampal neurons

Cell-specific expression and lipopolysaccharide-induced regulation of tumor necrosis factor alpha (TNFalpha) and TNF receptors in rat dorsal root ganglion

Stimulation of Group II Phospholipase A 2 Mrna Expression and Release in an Immortalized Astrocyte Cell Line (DITNC) by LPS, TNFα, and IL-1β

LRP1 Modulates the Microglial Immune Response Via Regulation of JNK and NF-κB Signaling Pathways

Identifying lysophosphatidic acid receptor subtype 1 (LPA1) as a novel factor to modulate microglial activation and their TNF-α production by activating ERK1/2

TLR agonists stimulate Nlrp3-dependent IL-1β production independently of the purinergic P2X7 receptor in dendritic cells and in vivo.

Pkc Mediates Lps-Induced Il-1 Beta Expression and Participates in the Pro-Inflammatory Effect of A(2a)R under High Glutamate Concentrations in Mouse Microglia

Toll-Like Receptors Promote Mitochondrial Translocation of Nuclear Transcription Factor Nuclear Factor of Activated T-Cells in Prolonged Microglial Activation

Botulinum toxin type A-targeted SPP1 contributes to neuropathic pain by the activation of microglia pyroptosis

Chronic TLR Stimulation Controls NLRP3 Inflammasome Activation Through IL-10 Mediated Regulation of NLRP3 Expression and Caspase-8 Activation

Interleukin-1β Induces Long-Term Potentiation of C-Fiber Evoked Field Potentials in Spinal Dorsal Horn in Rats with Neuropathic Pain